Post your job infront of 100,000+ qualified LP's and GP's.
Recently Filled Jobs
Firms you might be interested in
Velicept Therapeutics Raises An Additional $15M In Series B Round, Initiates Phase 2b Study Evaluating Once Daily Dosing Of Solabegron In Patients With Overactive Bladder (oab) And Receives Issuance Of Additional U.s. Patent
Posted on: Oct. 16, 2018, 11:41 p.m.
Velicept Therapeutics Raises an Additional $15 Million in Series B Round, Initiates Phase 2b Study Evaluating Once Daily Dosing of Solabegron in Patients with Overactive Bladder (OAB) and Receives Issuance of Additional U.S. Patent -Additional Funding to Advance Phase 2b Development Program in OAB- -Enrollment for Second Phase 2 Study Well Underway- -Issuance of U.S. Patent No. Full investment news articleRelevent to this post: Fountain Healthcare Partners Louisiana Economic Development,